Identification of targets and new developments in the treatment of multiple sclerosis – focus on cladribine
نویسندگان
چکیده
Orally available disease-modifying drugs for relapsing-remitting multiple sclerosis (MS) represent an unmet need for this chronic and debilitating disease. Among 5 currently investigated drugs at phase 3 clinical stage, promising efficacy data for fingolimod and oral cladribine have recently been published. However, benefits need to be weighed against the risks to define the role of these compounds within current treatment regimens. In this review, data on the efficacy of a promising compound, oral cladribine, are discussed and balanced with known and anticipated risks in a postmarketing era, and finally gives an outlook on the potential place of this drug in treatment algorithms for MS in the future.
منابع مشابه
P 64: Micro-Rna Disorder and Multiple Sclerosis
Noncoding ribonucleic acids micro-RNA is involved in the regulation of gene expression have major roles in the post-transcriptional level. A micro-RNA alone several causes down regulation of mRNA transcript of the target. Thus, small changes in the expression of a micro RNA may lead to significant changes in gene expression are different. Micro- RNA as key regulators of immune cell lineage diff...
متن کاملO 14: Differentiating Demyelinating Disorders of the Central Nervous System – a Focus on Multiple Sclerosis and Neuromyelitis-Optica Spectrum Disorders
Significant advances have been made in diagnosis and therapy of demyelinating disorders of the central nervous system. The most common entities of this disorders in adults – multiple sclerosis and neuromyelitis optica were initially thought to be different phenotypes of more or less the same disease. During the last ten years, this view was subsequently changed and the term neuromyelitis ...
متن کاملA Glance on Diagnosis and Ttreatment of Profound Fatigue in Multiple Sclerosis
Multiple Sclerosis (M.S) is one of the prevalent diseases of the central nervous system which cause disability in young adults. This appears as neural signs in different parts and various times. The main defect is local deterioration or destruction of myelin tissue in the brain and spinal cord. Profound fatigue is one the most common symptoms of this disease. Because MS is prevalent in middle a...
متن کاملCurrent and Emerging Therapies for the Treatment of Multiple Sclerosis: Focus on Cladribine
Multiple Sclerosis (MS) is a chronic inflammatory, immune-mediated, demyelinating disorder of the central nervous system with a heterogeneous clinical presentation and pathology in which activated lymphocytes play an important role in mediating tissue damage. Until recently, all first line therapies for MS were injectable. Several oral medications have been studied for preventative treatment of...
متن کاملO19: Recent Developments in the Treatment of Anxiety, Trauma, and Emotional Disorders
Advances in the treatment anxiety, trauma, and emotional disorders have been the focus of numerous international research efforts, including transdiagnostic approaches, internet-delivered treatments, and combined medication and cognitive-behavioral strategies. Recent research have identified emerging strategies for improving immediate efficacy, availability and dissemination, treatment engageme...
متن کامل